The rehabilitation robots market is characterized by transformative advancements and a growing emphasis on improving patient outcomes. The rehabilitation robots market is expected to grow at a CAGR of 17.5% during the forecast period of 2024 to 2032. The drivers, including technological advancements, the rising incidence of neurological disorders, and the increasing aging population, underline the market's transformative forces.
Ankylosing spondylitis (AS) is a chronic inflammatory disease that primarily affects the spine, causing pain, stiffness, and impaired mobility. The ankylosing spondylitis market is expected to grow at a CAGR of 8.5% during the forecast period of 2024 to 2032, propelled by advancements in biological therapies, a patient-centric approach with support programs, and increasing awareness leading to early diagnosis. However, the high cost of biologic therapies poses a notable restraint. Market segmentation reflects the dynamic preferences for AS drugs and regional variations in disease prevalence.
The small-volume parenteral (SVP) market is expected to grow at a CAGR of 7.8% during the forecast period of 2024 to 2032. The SVP market is poised for substantial growth, driven by factors such as the rising prevalence of chronic diseases, advancements in drug development, and demographic shifts. While regulatory challenges pose a restraint, the market is adapting to meet quality assurance requirements.
Laboratory filtration market is Expected to Grow at 7.5% by 2031. Technical developments, growing use of filtration technologies in biotechnology and drug discovery and development, clinical laboratories has assisted the laboratory filtration market to achieve impressive growth rate. Laboratory filtration solutions are used in processes of drug screening, DNA and protein separation, cell culture, and other separation and filtration processes. Growing biopharmaceutical research activities and urge for rapid drug commercialization are the prime drivers of laboratory filtration market.
The worldwide biomarkers market is predicted to grow at 12.5% by 2031. Growing expenditure on health care and research & development activities plus enhanced utility of biomarkers for diagnostics are predicted to stimulate the growth of the global biomarkers market. The growth and expansion of the industry will also be supported by the low prices of clinical trials in emerging nations and new initiatives taken by the firms who are into the biomarker research business.
Pharmaceutical API
